Ocular Therapeutix Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters Catalyzing the Future of Eye Care Innovations
Ocular Therapeutix Announces Successful Closure of Public Offering: A Milestone towards Advancing Innovations in Eye TherapiesBEDFORD, Mass., Dec. 18, 2023 - Ocular Therapeutix, Inc. (Nasdaq: OCUL), a leading biopharmac...
Dec 18, 2023
• Major Pharmaceutical Preparations Industry
Financing Agreement